Jeffrey Wiezorek Insider Trading
Get free email notifications about insider trading for Jeffrey Wiezorek.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey Wiezorek. Jeffrey Wiezorek is a SVP Clinical Development in Kite Pharma, Inc. ($KITE) and a VP Clinical Development in Kite Pharma, Inc. ($KITE).
Address: 2225 COLORADO AVENUE SANTA MONICA 90404 CA
Companies in which Jeffrey Wiezorek is an Insider
Kite Pharma, Inc.
Trading Symbol: KITEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jeffrey Wiezorek: SVP Clinical Development, VP Clinical Development
Holdings: 11,150 shares
Current Value: $594,518
Latest Transaction: Oct 05 2017
$KITE Market Capitalization: $2.64B
$KITE Previous Close: $53.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jeffrey Wiezorek
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 05 2017 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | D | 46.09 | 38,500 | 1,774,465 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | D | 63.87 | 14,850 | 948,470 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | D | 63.87 | 11,550 | 737,699 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | D | 51.96 | 5,031 | 261,411 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | D | 51.96 | 11,069 | 575,145 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | D | 6.89 | 29,167 | 200,961 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | D | 6.89 | 28,833 | 198,659 | 0 |